WHO Rabies Exposure Category
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Category I1–1
- Category II2–2
- Category III3–3
The WHO Rabies Exposure Category calculates predicting invasive bacterial infection probability and quantifying systemic host response to sepsis. Key inputs include exposure type. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
WHO rabies exposure categories: Category I (touching/feeding animals, licks on intact skin) — no PEP; Category II (nibbling of uncovered skin, minor scratches/abrasions without bleeding) — vaccine; Category III (transdermal bites/scratches, licks on broken skin, mucous-membrane contamination, bat exposures) — vaccine plus rabies immunoglobulin.
Clinical Indication
The WHO Rabies Exposure Category is indicated for bedside clinical practice to support WHO rabies exposure categories: Category I (touching/feeding animals, licks on intact skin) — no PEP; Category II (nibbling of uncovered skin, minor scratches/abrasions without bleeding) — vaccine; Category III (transdermal bites/scratches, licks on broken skin, mucous-membrane contamination, bat exposures) — vaccine plus rabies immunoglobulin.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.
Limitations & Contraindications
Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.
Clinical Pearls & Action Plan
Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.
Category = highest-risk exposure feature present
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| exposure_type | string | Yes | Type of contact |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 1–1 | Category I | Category I |
| 2–2 | Category II | Category II |
| 3–3 | Category III | Category III |
Evidence-Based References (EBM)
- World Health Organization. Rabies vaccines: WHO position paper. Wkly Epidemiol Rec. 2018;93(16):201-220. (exposure categories I-III)